Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes

Clinicians and patients are rapidly adapting GLP-1 receptor agonists as efficacious and safe therapeutic options for managing type 2 diabetes (T2DM). GLP-1 receptor agonists stimulate insulin production and secretion from the pancreatic β cells in a glucose-dependent manner, improve gastric emptying...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current diabetes reports 2013-10, Vol.13 (5), p.663-668
1. Verfasser:	Unger, Jeff
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 1 - metabolism Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - metabolism Glucagon-Like Peptide 1 - pharmacology Glucagon-Like Peptide 1 - therapeutic use Glucagon-Like Peptide-1 Receptor Humans Hypoglycemia - complications Medicine Medicine & Public Health Off-Label Use Receptors, Glucagon - agonists Receptors, Glucagon - deficiency Section Editor Treatment of Type 1 Diabetes (JR Unger
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!